Rockville-based research firm Westat has been awarded a contract by the U.S. Food and Drug Adminstration, to assist in policy creation and public messaging by the federal agency. The contract charges Westat with more than a dozen tasks to complete, including literature reviews, focus groups, cognitive interviews, pretesting, and experimental studies. The information gathered will give the FDA a sense of current consumer and medical professional opinions about products it regulates.
Westat will conduct in-person and virtual meetings of focus groups, as well as individual interviews. Participants will give their thoughts on a diverse array of products, ranging from sunscreens to CBD to genetically-engineered salmon. Westat will also be examining public opinion on product labeling and pharmaceutical advertising.
"Westat is a natural fit for this work. We have strong, established expertise in message testing and a team that specializes in qualitative analysis and reporting," Westat Vice President of Public Health and Epidemiology Kerry Levin, PhD said in a statement. "Our goal on these important tasks is to maintain a collaborative, collegial, client-centered relationship, and to successfully execute each project to meet the needs of FDA."
No comments:
Post a Comment